Patents by Inventor Nancy Shulman

Nancy Shulman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INDAZOLE PYRIDONE COMPOUNDS AND USES THEREOF
    Publication number: 20240182472
    Abstract: Novel tetracyclic pyridone compounds according to Formula I are provided, where R and X are defined herein. Pharmaceutical compositions containing such compounds, methods of using these compounds and compositions in the treatment and prevention of HBV infections are also provided.
    Type: Application
    Filed: October 3, 2023
    Publication date: June 6, 2024
    Inventors: Jeffery Zablocki, Hassan Javanbakht, Keting Chu, Dmitry Koltun, Nancy Shulman
  • Prediction of HCV Viral Kinetics in Interferon-Free Treatment
    Publication number: 20120196272
    Abstract: The present invention is based on the discovery of associations that exist between single nucleotide polymorphisms (SNPs) on chromosome 19 and virological outcomes in a diverse population of patients with hepatitis C virus (HCV) who received interferon-free treatment.
    Type: Application
    Filed: July 29, 2011
    Publication date: August 2, 2012
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Tom Chu, Uri A. Lopatin, Nancy Shulman
  • Single Nucleotide Polymorphisms That Predict HCV Treatment Outcomes
    Publication number: 20120094389
    Abstract: The present invention is based on the discovery of associations that exist between single nucleotide polymorphisms (SNPs) on chromosome 4 and virological outcomes in a diverse population of patients with hepatitis C virus (HCV) who received interferon-based treatment.
    Type: Application
    Filed: April 11, 2011
    Publication date: April 19, 2012
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Uri Lopatin, Tom Chu, Laurent Essioux, Soren Germer, Nancy Shulman, James A. Thommes
  • Prediction of Early Virological Response in HCV Treatment
    Publication number: 20120094284
    Abstract: The present invention is based on the discovery of associations that exist between single nucleotide polymorphisms (SNPs) on chromosome 19 and virological outcomes in a diverse population of patients with hepatitis C virus (HCV) who received interferon-based treatment.
    Type: Application
    Filed: April 11, 2011
    Publication date: April 19, 2012
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Uri Lopatin, Tom Chu, Laurent Essioux, Soren Germer, Nancy Shulman, James A. Thommes